A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

NCT01937871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

909

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostate Hyperplasia
Erectile Dysfunction

Interventions

DRUG: 5 mg Tadalafil
DRUG: Placebo
DRUG: 0.2 mg Tamsulosin

Sponsor

Eli Lilly and Company